Checkpoint Therapeutics Inc (CKPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,042 | 6,604 | 4,703 | 4,951 | 11,241 |
| Receivables | N/A | N/A | N/A | 41 | N/A |
| TOTAL | $34,164 | $7,471 | $5,179 | $5,670 | $11,975 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $34,164 | $7,471 | $5,179 | $5,670 | $11,975 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,609 | 19,898 | 17,644 | 21,294 | 22,100 |
| Other current liabilities | 260 | 198 | 125 | 125 | 125 |
| TOTAL | $17,869 | $20,096 | $17,769 | $21,419 | $22,225 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $17,869 | $20,096 | $17,769 | $21,419 | $22,225 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 87,020 | 83,764 | 48,833 | 45,018 | 36,850 |
| Common Shares | 8 | 5 | 5 | 4 | 4 |
| Retained earnings | -381,785 | -370,573 | -341,673 | -331,948 | -325,278 |
| Other shareholders' equity | 0 | 7,638 | 0 | 0 | 3,419 |
| TOTAL | $16,295 | $-12,625 | $-12,590 | $-15,749 | $-10,250 |
| Total Liabilities And Equity | $34,164 | $7,471 | $5,179 | $5,670 | $11,975 |